Company: ABBV
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001104659-25-013467
Chunk: 1

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01      Regulation FD Disclosure.  

On February 14, 2025, the Company issued a
press release announcing the appointment of Mr. Michael as Chairman, effective July 1, 2025. A copy of the press release is
furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in
this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities
of that Section and shall not be incorporated by reference into any registration statement or other document filed pursuant to the
Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.